Global Large Volume Parenteral Market: Overview
Parenteral formulations refer to sterile liquid or solid drug dosages packaged in either single or multi dose containers to be administered via a route other than the digestive tract, such as by intramuscular, subcutaneous, or intravenous injections. Parenteral drug administration is known to provide maximum efficacy and bioavailability and is preferred over oral dosages in a vast number of instances. Broadly, parenteral preparations are segmented on the basis of the content of the dosage into large and small volume parenteral formulations.
Small volume parenteral preparations include dosages that are 100 ml or less and prepared as single or multiple dosages. Large volume parenteral (LVP) preparations, on the other hand, are dosages more than 100 ml volumes of intravenous solutions, commonly prescribed to correct fluid and electrolyte disturbances, nutrition, or to act as a vehicle for administering some kind of drug to the body. Commonly used large volume parenteral preparations include infusions of amino acid, mannitol, dextrose, lactated ringer injection, ringer’s injection, and sodium chloride injection. This report on the global large volume parenteral market presents an overview of the market on the global, regional, and country levels.
Global Large Volume Parenteral Market: Scope of the Report
The report presents vast qualitative as well as quantitative insights about the market and its key aspects in present times. The report also includes vast projections regarding the growth prospects of the market over the period between 2016 and 2024 based on volume and revenue, with 2015 considered the base year. It provides a comprehensive analytical overview of the key factors expected to have a notable impact on the market’s future growth prospects, including drivers, challenges, and growth opportunities.
The report analyzes the degree of competition in the global large volume parenteral market with the help of Porter’s Five Forces analysis. The report also comprises a qualitative overview of the market’s attractiveness, wherein key product varieties and countries are analyzed on the basis of attractiveness for each region. Aspects such as profit margin, raw material availability, market size, growth rate, competition, recent technological developments, and other factors representing the current growth opportunity held by the market or its sectors are also evaluated to derive the market’s general attractiveness. The report also comprises an analysis of the market’s projected price trends between 2016 and 2024.
Global Large Volume Parenteral Market: Drivers and Restraints
In the past few years, there has been a substantial rise in the overall demand for large volume parenteral preparations. The constantly rising numbers of surgeries and an increasing rate of hospitalization are considered to be the key factors to have paved the way for the market to secure promising growth avenues. Moreover, the rising demand for safer, faster, and more effective methods of drug administration in patients undergoing surgeries have also leveraged the demand for LPV preparations globally. The increasing consumer acceptance for single dosage vaccines, and drugs for central nervous systems disorders, diabetes, and oncology is also expected to drive the demand for large volume parenteral preparations.
Global Large Volume Parenteral Market: Segmentation
The large volume parenteral market has been analyzed in the report through three broad categories namely, nutritious injections, therapeutic injections, and injections for fluid balance. Of these, fluid balance injections are used to administer a variety of electrolytes to trauma patients and to patients who are in the need of electrolytes such as chloride, sodium, and potassium. Therapeutic injections are widely used to administer vaccines, anti-infective drugs, oncology drugs, diabetes drugs, and gastrointestinal drugs. From a geographical perspective, the large volume parenteral market has been examined for regions such as North America, Europe, Asia Pacific, and Middle East and Africa.
Some of the key vendors operating in the global large volume parenteral market are Baxter Healthcare Corporation, Kelun Pharma, Patheon Inc., BAG Healthcare GmbH, Hospira, Inc., Otsuka Pharmaceutical, Teva Pharmaceutical Industries Limited, Wockhardt Ltd., Southwest Pharmaceutical Co. Ltd., and Cook Pharmica LLC.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.